Where this oesophageal cancer information comes from

All our information is checked by cancer specialists and surgeons who specialise in treating cancer. The names of our specialist reviewers are at the end of this page. We also try to find patients to review all our sections. If you have had oesophageal cancer, live in the UK and would like to become a patient reviewer, you can write to us by clicking on contact us.

Cancer Research UK
CancerStats Series

US National Cancer Institute
Information on the treatment of oesophageal cancer

Principles and practice of oncology (8th edition)
De Vita, V.T., Hellman, S. and Rosenberg S.A.
Lippincott, Williams and Wilkins, 2008

Cancer and its management (6th edition)
Tobias J and Hochhauser D
Wiley-Blackwell, 2010

TNM Classification of Malignant Tumours (7th edition)
International Union Against Cancer
L.H. Sobin, M.K. Gospodarowicz, Ch. Wittekind
John Wiley and Sons, Hoboken, New Jersey, 2009

AJCC Cancer Staging Manual (7th edition)
American Joint Committee on Cancer
Springer, 2010

Guidelines for the management of oesophageal and gastric cancer
British Society of Gastroenterology (BSG), 2011
Link to the BSG website

Management of oesophageal and gastric cancer
Scottish Intercollegiate Guidelines Network (SIGN), June 2006
Link to the SIGN website

Referral Guidelines for suspected cancer
The National Institute for Health and Clinical Excellence (NICE), June 2005
Link to the NICE website

Minimally invasive oesophagectomy
The National Institute for Health and Clinical Excellence (NICE), September 2011
Link to the NICE website

Photodynamic therapy for Barrett's oesophagus
The National Institute for Health and Clinical Excellence (NICE), June 2010
Link to the NICE website

Epithelial radiofrequency ablation for Barrett's oesophagus
The National Institute for Health and Clinical Excellence (NICE), May 2010
Link to the NICE website

Ablative therapies for Barrett's oesophagus
The National Institute for Health and Clinical Excellence (NICE), August 2010
Link to the NICE website

Endoscopic submucosal dissection of oesophageal dysplasia and neoplasia
The National Institute for Health and Clinical Excellence (NICE), September 2010
Link to the NICE website

Trastuzumab for treating metastatic gastric cancer
The National Institute for Health and Clinical Excellence (NICE), November 2010
Link to the NICE website

Palliative photodynamic therapy for advanced oesophageal cancer
The National Institute for Health and Clinical Excellence (NICE), January 2007
LINK to the NICE website

National Oesophago Gastric Cancer Audit
NHS Information Centre
Annual Report 2010 and 2012

Preoperative radiotherapy for esophageal carcinoma. Cochrane Review. Arnott SJ, Duncan W, Gignoux M, Girling DJ, Hansen HS, Launois B, Nygaard K, Parmar MKB, Rousell A, Spiliopoulos G, Stewart LA, Tierney JF, Wang M, Rhugang Z (Oesophageal Cancer Collaborative Group). In: The Cochrane Library, Issue 4, 2005. Chichester, UK: John Wiley and Sons, Ltd.

Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Review. Malthaner R, Fenlon D. In: The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley and Sons, Ltd.

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Gobs, V., Burmeister, B., Smithers, B.M., Foo, K.,Zalcberg, J. and Simes, J., for the Australasian Gastro-Intestinal Trials Group. Lancet Oncology, (2007), 8, 226-34.

Oesophageal cancer. Lagergren J and Lagergren P. British Medical Journal, 2010, Vol. 341. Clinical Review. DOI: 10.1136/bmj.c6280

Treatment for Barrett's oesophagus (Review). Rees JRE, Lao-Sirieix P, Wong A and Fitzgerald RC. In The Cochrane Library, Issue 7, 2011

Diagnosis and management of Barrett's oesophagus. Janowski J, Barr H, Wang K and Delaney B. BMJ. 2010 vol. 341 p. 597-602

Curative treatment of oesophageal carcinoma:current options and future developments. Wolf MC, Stahl M, Krause B et al. Radiation Oncology. 2011 6 (55)

Multimodality treatment for localized gastro oesophageal cancer. Okines AFC and Cunningham D. Annals of Oncology. 2010. 21 (supplement 7): vii286-vii293.

Esophageal cancer: Clinical practice guidelines for diagnosis, treatment and follow up. Stahl M, Budach W, Meyer HJ and Cervantes A. Annals of Oncology. 2010. 21 (supplement 5): v46-v49.

Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer. Courrech Staal EFW, Aleman BMP, Boot H et al. British Journal of Surgery. 2010. 97 p. 1482-1496

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma:an updated meta analysis. Sjoquist KM, Burmeister BH, Smithers BM et al. Lancet Oncology. 2011. 12. p. 681-692

Preoperative chemoradiotherapy for esophageal or junctional cancer. van Hagen P, Hulshof MCCM, van Lanschot JJB et al. New England Journal of Medicine. 2012. 366(22). p.2074-2084

Optimal therapeutic strategies for resectable oesophageal or oesophagogastric junction cancer. Bystricky B, Okines A and Cunningham D. Drugs. 2011. 71 (5). p. 541-555

Multimodality therapy for adenocarcinoma of the esophagus, gastric cardia and upper gastric third. Reynolds JV, Murphy TJ and Ravi N. Recent Results in Cancer Research. 2010. 182. p. 155-166

Mr William Allum, MBChB, MD, FRCS
Dr Tom Crosby, MBBS, MRCP, FRCR, Consultant Clinical Oncologist
Dr Patricia Fisher, BSc MBChB (Hons) MRCP FRCR
Mr Richard Steyn, MS FRCSEd(C-Th) FIMCRCSEd MRCGP DRCOG

Dee McLean - McDee Art, Medical Illustration